These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26797100)

  • 1. Synthesis and in Vitro Screening of New Series of 2,6-Dipeptidyl-anthraquinones: Influence of Side Chain Length on HIV-1 Nucleocapsid Inhibitors.
    Frecentese F; Sosic A; Saccone I; Gamba E; Link K; Miola A; Cappellini M; Cattelan MG; Severino B; Fiorino F; Magli E; Corvino A; Perissutti E; Fabris D; Gatto B; Caliendo G; Santagada V
    J Med Chem; 2016 Mar; 59(5):1914-24. PubMed ID: 26797100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification by high throughput screening of small compounds inhibiting the nucleic acid destabilization activity of the HIV-1 nucleocapsid protein.
    Shvadchak V; Sanglier S; Rocle S; Villa P; Haiech J; Hibert M; Van Dorsselaer A; Mély Y; de Rocquigny H
    Biochimie; 2009 Jul; 91(7):916-23. PubMed ID: 19401213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Natural Linker Configuration in 2,6-Dipeptidyl-Anthraquinones Enhances the Inhibition of TAR RNA Binding/Annealing Activities by HIV-1 NC and Tat Proteins.
    Sosic A; Saccone I; Carraro C; Kenderdine T; Gamba E; Caliendo G; Corvino A; Di Vaio P; Fiorino F; Magli E; Perissutti E; Santagada V; Severino B; Spada V; Fabris D; Frecentese F; Gatto B
    Bioconjug Chem; 2018 Jul; 29(7):2195-2207. PubMed ID: 29791798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifaceted Aspects of HIV-1 Nucleocapsid Inhibition by TAR-Targeting Peptidyl-Anthraquinones Bearing Terminal Aromatic Moieties.
    Sosic A; Frecentese F; Olivato G; Rollo D; Carraro C; Gamba E; Santagada V; Gatto B
    Viruses; 2022 Sep; 14(10):. PubMed ID: 36298688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional and structural characterization of 2-amino-4-phenylthiazole inhibitors of the HIV-1 nucleocapsid protein with antiviral activity.
    Mori M; Nucci A; Lang MC; Humbert N; Boudier C; Debaene F; Sanglier-Cianferani S; Catala M; Schult-Dietrich P; Dietrich U; Tisné C; Mely Y; Botta M
    ACS Chem Biol; 2014 Sep; 9(9):1950-5. PubMed ID: 24988251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of HIV-1 Nucleocapsid Protein Inhibition by Lysyl-Peptidyl-Anthraquinone Conjugates.
    Sosic A; Sinigaglia L; Cappellini M; Carli I; Parolin C; Zagotto G; Sabatino G; Rovero P; Fabris D; Gatto B
    Bioconjug Chem; 2016 Jan; 27(1):247-56. PubMed ID: 26666402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel 2-benzoxazolinone derivatives with specific inhibitory activity against the HIV-1 nucleocapsid protein.
    Gamba E; Mori M; Kovalenko L; Giannini A; Sosic A; Saladini F; Fabris D; Mély Y; Gatto B; Botta M
    Eur J Med Chem; 2018 Feb; 145():154-164. PubMed ID: 29324338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of virtual screening for discovering antiretroviral compounds interacting with the HIV-1 nucleocapsid protein.
    Mori M; Schult-Dietrich P; Szafarowicz B; Humbert N; Debaene F; Sanglier-Cianferani S; Dietrich U; Mély Y; Botta M
    Virus Res; 2012 Nov; 169(2):377-87. PubMed ID: 22634301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and Synthesis of DiselenoBisBenzamides (DISeBAs) as Nucleocapsid Protein 7 (NCp7) Inhibitors with anti-HIV Activity.
    Sancineto L; Mariotti A; Bagnoli L; Marini F; Desantis J; Iraci N; Santi C; Pannecouque C; Tabarrini O
    J Med Chem; 2015 Dec; 58(24):9601-14. PubMed ID: 26613134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-HIV activity of semisynthetic derivatives of andrographolide and computational study of HIV-1 gp120 protein binding.
    Uttekar MM; Das T; Pawar RS; Bhandari B; Menon V; Nutan ; Gupta SK; Bhat SV
    Eur J Med Chem; 2012 Oct; 56():368-74. PubMed ID: 22858223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-Based Identification of HIV-1 Nucleocapsid Protein Inhibitors Active against Wild-Type and Drug-Resistant HIV-1 Strains.
    Mori M; Kovalenko L; Malancona S; Saladini F; De Forni D; Pires M; Humbert N; Real E; Botzanowski T; Cianférani S; Giannini A; Dasso Lang MC; Cugia G; Poddesu B; Lori F; Zazzi M; Harper S; Summa V; Mely Y; Botta M
    ACS Chem Biol; 2018 Jan; 13(1):253-266. PubMed ID: 29235845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, anti-HIV evaluation and molecular modeling of piperidine-linked amino-triazine derivatives as potent non-nucleoside reverse transcriptase inhibitors.
    Chen X; Zhan P; Liu X; Cheng Z; Meng C; Shao S; Pannecouque C; De Clercq E; Liu X
    Bioorg Med Chem; 2012 Jun; 20(12):3856-64. PubMed ID: 22591854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of 2-(2,6-dibromophenyl)-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents.
    Rawal RK; Tripathi R; Katti SB; Pannecouque C; De Clercq E
    Eur J Med Chem; 2008 Dec; 43(12):2800-6. PubMed ID: 18242784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological evaluation of optically pure functionalized spiro[5,5]undecane-1,5,9-triones as HIV-1 inhibitors.
    Ramachary DB; Reddy YV; Banerjee A; Banerjee S
    Org Biomol Chem; 2011 Nov; 9(21):7282-6. PubMed ID: 21915419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (Thia)calixarenephosphonic Acids as Potent Inhibitors of the Nucleic Acid Chaperone Activity of the HIV-1 Nucleocapsid Protein with a New Binding Mode and Multitarget Antiviral Activity.
    Humbert N; Kovalenko L; Saladini F; Giannini A; Pires M; Botzanowski T; Cherenok S; Boudier C; Sharma KK; Real E; Zaporozhets OA; Cianférani S; Seguin-Devaux C; Poggialini F; Botta M; Zazzi M; Kalchenko VI; Mori M; Mély Y
    ACS Infect Dis; 2020 Apr; 6(4):687-702. PubMed ID: 32045204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and SAR of new substituted purines bearing aryl groups at N9 position as HIV-1 Tat-TAR interaction inhibitors.
    Pang R; Zhang C; Yuan D; Yang M
    Bioorg Med Chem; 2008 Sep; 16(17):8178-86. PubMed ID: 18693018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, anti-HIV and anti-oxidant activities of caffeoyl 5,6-anhydroquinic acid derivatives.
    Ma CM; Kawahata T; Hattori M; Otake T; Wang L; Daneshtalab M
    Bioorg Med Chem; 2010 Jan; 18(2):863-9. PubMed ID: 20004585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arylazolyl(azinyl)thioacetanilides. Part 16: Structure-based bioisosterism design, synthesis and biological evaluation of novel pyrimidinylthioacetanilides as potent HIV-1 inhibitors.
    Li X; Lu X; Chen W; Liu H; Zhan P; Pannecouque C; Balzarini J; De Clercq E; Liu X
    Bioorg Med Chem; 2014 Oct; 22(19):5290-7. PubMed ID: 25150090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of N-aryl pyrrolidinones as novel anti-HIV-1 agents. Part 1.
    Wu B; Kuhen K; Ngoc Nguyen T; Ellis D; Anaclerio B; He X; Yang K; Karanewsky D; Yin H; Wolff K; Bieza K; Caldwell J; He Y
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3430-3. PubMed ID: 16632349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of a new derivative of bevirimat that targets the Gag CA-SP1 cleavage site.
    Coric P; Turcaud S; Souquet F; Briant L; Gay B; Royer J; Chazal N; Bouaziz S
    Eur J Med Chem; 2013 Apr; 62():453-65. PubMed ID: 23399723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.